S&P 500
(-0.46%) 5 048.42 points
Dow Jones
(-0.98%) 38 086 points
Nasdaq
(-0.64%) 15 612 points
Oil
(1.20%) $83.80
Gas
(-2.66%) $1.609
Gold
(0.27%) $2 344.60
Silver
(0.37%) $27.45
Platinum
(1.10%) $925.90
USD/EUR
(-0.30%) $0.932
USD/NOK
(-0.25%) $10.96
USD/GBP
(-0.41%) $0.799
USD/RUB
(-0.06%) $92.27

Realtime updates for Merck & Co Inc [6MK.DE]

Exchange: XETRA Industry: Pharmaceuticals, Biotechnology & Life Sciences
Upcoming Earnings Alert

Quarter results today
(bmo 2024-04-25)

Expected move: +/- 0.00%

Last Updated25 Apr 2024 @ 11:35

1.52% 120.60

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:35):

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines...

Stats
Today's Volume 1 391.00
Average Volume 997.00
Market Cap 305.44B
EPS €0 ( 2024-04-24 )
Last Dividend €0.730 ( 2023-09-14 )
Next Dividend €0 ( N/A )
P/E 927.69
ATR14 €0.430 (0.36%)

Merck & Co Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Merck & Co Inc Financials

Annual 2023
Revenue: €60.12B
Gross Profit: €43.99B (73.17 %)
EPS: €0.140
Q4 2023
Revenue: €14.63B
Gross Profit: €10.72B (73.26 %)
EPS: €-0.480
Q3 2023
Revenue: €15.96B
Gross Profit: €11.70B (73.29 %)
EPS: €1.870
Q2 2023
Revenue: €15.04B
Gross Profit: €11.01B (73.24 %)
EPS: €-2.35

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.690
(N/A)
€0.730
(N/A)
€0.730
(N/A)
€0.730
(N/A)
€0.730
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Merck & Co Inc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.55 - Stable (30.93%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.380 2009-12-11
Last Dividend €0.730 2023-09-14
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 56 --
Total Paid Out €28.56 --
Avg. Dividend % Per Year 0.00% --
Score 4.6 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 6.55
Div. Directional Score 8.48 --
Next Divdend (Est)
(2024-07-01)
€0.745 Estimate 22.11 %
Dividend Stability
0.59 Average
Dividend Score
4.60
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
KCO.DE Ex Dividend Junior 2023-05-18 Sporadic 0 0.00%
TCM1.F Ex Dividend Knight 2023-08-09 Semi-Annually 0 0.00%
DUE.DE Ex Dividend Junior 2023-05-15 Annually 0 0.00%
MRK.DE Ex Dividend Knight 2023-05-02 Annually 0 0.00%
ABR.DE Ex Dividend Knight 2023-08-30 Quarterly 0 0.00%
VVV3.DE Ex Dividend Junior 2023-06-22 Annually 0 0.00%
FPE3.DE Ex Dividend Knight 2023-05-04 Annually 0 0.00%
ORC.DE Ex Dividend Knight 2023-10-11 Quarterly 0 0.00%
BAC.DE Ex Dividend Knight 2023-10-09 Quarterly 0 0.00%
HHFA.DE Ex Dividend Junior 2023-06-16 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.006071.5009.8810.00[0 - 0.5]
returnOnAssetsTTM0.003421.2009.8910.00[0 - 0.3]
returnOnEquityTTM0.008881.500-1.012-1.519[0.1 - 1]
payoutRatioTTM20.40-1.00010.00-10.00[0 - 1]
currentRatioTTM1.2520.8008.746.99[1 - 3]
quickRatioTTM0.6790.800-0.713-0.570[0.8 - 2.5]
cashRatioTTM0.2661.5009.6310.00[0.2 - 2]
debtRatioTTM0.329-1.5004.52-6.78[0 - 0.6]
interestCoverageTTM3.181.0009.939.93[3 - 30]
operatingCashFlowPerShareTTM5.132.008.2910.00[0 - 30]
freeCashFlowPerShareTTM3.612.008.2010.00[0 - 20]
debtEquityRatioTTM0.933-1.5006.27-9.40[0 - 2.5]
grossProfitMarginTTM0.7321.0001.1381.138[0.2 - 0.8]
operatingProfitMarginTTM0.05981.000-0.804-0.804[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3711.0009.059.05[0.2 - 2]
assetTurnoverTTM0.5640.8009.587.66[0.5 - 2]
Total Score10.41

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM882.681.00010.000[1 - 100]
returnOnEquityTTM0.008882.50-0.651-1.519[0.1 - 1.5]
freeCashFlowPerShareTTM3.612.008.8010.00[0 - 30]
dividendYielPercentageTTM2.361.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM5.132.008.2910.00[0 - 30]
payoutRatioTTM20.401.50010.00-10.00[0 - 1]
pegRatioTTM44.521.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2161.0007.090[0.1 - 0.5]
Total Score6.55

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators